Hunan Nucien Pharmaceutical Co (SHSE:688189) Treasury Stock: ¥-30.0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688189 Hunan Nucien Pharmaceutical Co Ltd SHSE:688189
47 GF Score
Price ¥6.85
GF Value ¥3.18
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Hunan Nucien Pharmaceutical Co Treasury Stock?

Hunan Nucien Pharmaceutical Co SHSE:688189 -0.44% 47 Treasury Stock is ¥-30.0 Mil as of Jun. 2026. GuruFocus rates SHSE:688189 with a GF Score™ of 47/100 and a GF Value™ of ¥3.18 (Significantly Overvalued). The stock has 2 warning signs investors should review.

Treasury stock is the portion of shares that a company keeps in their own treasury. Hunan Nucien Pharmaceutical Co's treasury stock for the quarter that ended in Jun. 2026 was ¥-30.0 Mil.

Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place.

Hunan Nucien Pharmaceutical Co Treasury Stock Historical Data

* Premium members only.

The historical data trend for Hunan Nucien Pharmaceutical Co's Treasury Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hunan Nucien Pharmaceutical Co Treasury Stock Chart

Hunan Nucien Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Treasury Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 -10.00 -26.14

Hunan Nucien Pharmaceutical Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Treasury Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -11.97 -11.97 -26.14 -29.25 -30.00
SHSE:688189
47GF Score
Hunan Nucien Pharmaceutical Co Ltd SHSE:688189
Treasury Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hunan Nucien Pharmaceutical Co Treasury Stock Calculation

The portion of shares that a company keeps in their own treasury. Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place. These shares don't pay dividends, have no voting rights, and should not be included in shares outstanding calculations.

Frequently Asked Questions Learn more about Treasury Stock →
What does a Treasury Stock of ¥-30.0 Mil mean?
Hunan Nucien Pharmaceutical Co (SHSE:688189) has a Treasury Stock of ¥-30.0 Mil as of Jun. 2026. Treasury stock is a contra-equity item that records the amount of stock not issued to shareholders. View historical data for Hunan Nucien Pharmaceutical Co and its competitors.
Is Hunan Nucien Pharmaceutical Co's Treasury Stock too high?
Hunan Nucien Pharmaceutical Co's current Treasury Stock is ¥-30.0 Mil. Overall, Hunan Nucien Pharmaceutical Co has a GF Score™ of 47/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Hunan Nucien Pharmaceutical Co's Treasury Stock compare to ZTS?
Hunan Nucien Pharmaceutical Co's Treasury Stock of ¥-30.0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Treasury Stock for a Drug Manufacturers company?
A good Treasury Stock depends on the Drug Manufacturers industry context. However, Treasury Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Treasury Stock mean?
A high Treasury Stock can signal that a stock is expensive relative to its fundamentals. Treasury stock is a contra-equity item that records the amount of stock not issued to shareholders. View historical data for Hunan Nucien Pharmaceutical Co and its competitors. Hunan Nucien Pharmaceutical Co's current Treasury Stock is ¥-30.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hunan Nucien Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Hunan Nucien Pharmaceutical Co (SHSE:688189) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥3.18, compared to a current price of ¥6.85 — trading 115.4% above its estimated fair value. The current Treasury Stock is ¥-30.0 Mil. Hunan Nucien Pharmaceutical Co's overall GF Score™ is 47/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Treasury Stock calculated?
Treasury Stock is calculated from a company's financial statements. For Hunan Nucien Pharmaceutical Co (SHSE:688189), the current Treasury Stock is ¥-30.0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hunan Nucien Pharmaceutical Co (SHSE:688189) Overvalued in 2026?

Based on GuruFocus' analysis, Hunan Nucien Pharmaceutical Co stock appears to be overvalued. The current stock price of ¥6.85 is trading 115.4% above its estimated GF Value™ of ¥3.18. GuruFocus considers Hunan Nucien Pharmaceutical Co to be Significantly Overvalued.

Key valuation signals for SHSE:688189:

  • Treasury Stock: ¥-30.0 Mil
  • GF Value™: ¥3.18 vs. price of ¥6.85 (115.4% above fair value)
  • GF Score™: 47/100 with 2 warning signs

No single metric tells the full story. See the SHSE:688189 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Hunan Nucien Pharmaceutical Co Business Description

Address No. 1 Kangli Road, Liuyang Economic and Technological Development Zone, Hunan Province, Changsha, CHN, 510100
Hunan Nucien Pharmaceutical Co Ltd is a pharmaceutical company integrating drug research and development, production and sales. The company focuses on anti-infection, cardio-cerebral vascular, anti-tumor and other pharmaceutical fields. The company's business scope includes the manufacturing and sales of chemical pharmaceutical preparations, chemical pharmaceutical raw materials, biological drugs, chemical reagents, and auxiliaries.
47GF Score

Get the complete analysis for SHSE:688189

Treasury Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥6.85
Price
¥3.18
GF Value